ALDH1 subtype-specific inhibitor targets key cell populations in triple negative breast cancer
PEREZ, M.; Farres, J.; Rebollido-Rios, R.; Constantinescu, A.; Pequerul, R.; Janji, B.; Kumar, A.; Pares-Casampera, X.; Colignon, D.; Berrou, A.; Fournet, G.; Martin, G.; Ceylan, I.
Show abstract
Aggressive breast cancer subtypes, particularly triple-negative breast cancer (TNBC), lack effective targeted therapies, requiring novel approaches. This study focuses on the aldehyde dehydrogenase 1A (ALDH1A) subfamily, comprising ALDH1A1, ALDH1A2, and ALDH1A3, and their roles in tumor biology and the tumor microenvironment. Comprehensive transcriptomic and single-cell analyses revealed subtype- and cell-specific expression patterns of ALDH1A isoforms, with ALDH1A3 predominantly expressed in epithelial cancer cells of basal-like tumors, while ALDH1A1 and ALDH1A2 were expressed in stromal and immune-associated subpopulations. Guided by these findings, we developed ABD0171, a selective ALDH1A3 inhibitor that demonstrated potent isoform-specific activity. ABD0171 effectively disrupted key pathways in TNBC cells in vitro, including IL6/JAK/STAT3, tPA and Src/FAK, and exhibited superior selectivity, robust antitumor and antimetastatic effects, and a favorable safety profile in vivo. These results establish ALDH1A3 as a promising therapeutic target and validate ABD0171 as a candidate to address current challenges in aggressive breast cancers.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer 96%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 95%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 95%
Similar papers in this journal
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 96%
- Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A 96%
- Rapid Resistance To Bet Inhibitors Is Mediated By Fgfr1 In Glioblastoma 95%
Similar papers in this journal
- The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays 93%
- RNA Sequencing-Based Single Sample Predictors of Molecular Subtype and Risk of Recurrence for Clinical Assessment of Early-Stage Breast Cancer 93%
- The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer 92%
Similar papers in this journal
- Histone deacetylase inhibitor induces acetyl-CoA depletion leading to lethal metabolic stress in RAS-pathway activated cells 94%
- A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancer 94%
- The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.